Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA Lower vs Upper Punctum Insertion Post-Cataract Surgery
NCT05372315Phase 4Completed
- Sponsor
- iWorks Laser & Vision Center
- Start
- Jun 2022
- Primary completion
- Oct 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ozurdex in ocular inflammation (2 arms), sponsored by iWorks Laser & Vision Center. Primary endpoints: Participants With Complete Absence of Ocular Pain at Day 8 and Participants With Zero Cells on Day 14. Started Jun 2022; status: completed.
02
Drugs
ozurdex
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT05372315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05372315.